The placebo shrine.

The placebo shrine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The placebo shrine. Abstract Text:

The placebo shrine. Publishing Authors By Initials

For similar pharmaceutical preparations: placebos research abstracts see: pharmaceutical preparations: placebos research

PUBMED ID PMID:

MEDLINE DATE:

The placebo shrine. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical pharmacy and therapeutics

VOLUME: 16

Page Numbers: 225-30

Journal Abbreviation: J Clin Pharm Ther

ISSN: 0269-4727

DAY: 28

MONTH: Aug

YEAR: 1991

The placebo shrine. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8704308

The placebo shrine. Keywords Mesh Terms:

KEYWORDS: Placebos

MESH TERMS:

Chemical & Substance for Abstract: The placebo shrine. Information

Substance Name: Placebos

Registry Number: 0

Grant and Affiliation Information for The placebo shrine.

AFFILIATION: Girton College, University of Cambridge, U.K.

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Pharm Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The placebo shrine Related Publications

• 5alpha-reductase: history and clinical importance.
• A novel assay for monitoring internalization of nanocarrier coupled antibodies.
• Anxiety sensitivity and auditory perception of heartbeat.
• Cannabis laws: an analysis of costs.
• Continuous participation in voluntary groups as a protective factor for the psychological well-being of adults who develop functional limitations: evidence from the national survey of families and households.
• Darkness descends with two Rabs.
• Evaluation of expression based markers for the detection of breast cancer cells.
• Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.
• Granulocyte transfusions in the G-CSF era. Where do we stand?
• Histone deacetylase inhibitors selectively suppress expression of HDAC7.
• Histone deacetylase inhibitors: molecular mechanisms of action.
• Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.
• Interrogational neuroimaging in counterterrorism: a "no-brainer" or a human rights hazard?
• MOSQUITOES (CULICIDAE) BITING A FISH (PERIOPHTHALMIDAE).
• Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia.
• Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.
• Morbidity and cost of atopic eczema in Australia.
• One-pot terminal alkene homologation using a tandem olefin cross-metathesis/allylic carbonate reduction sequence.
• Penetrating spinal injury with wooden fragments causing cauda equina syndrome: case report and literature review.
• Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees.
• Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer.
• Regulation of central melanocortin signaling by interleukin-1 beta.
• Self-consistent tumor control probability and normal tissue complication probability models based on generalized EUD.
• Skin cancer: a practical guide to management.
• The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.
• The role of functional imaging in the diagnosis and management of late normal tissue injury.
• The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.
• The way of all flesh - the 21st Century.
• Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis.
• Who really wants to save the apes?